SHL — Sonic Healthcare Income Statement
0.000.00%
- AU$10.38bn
- AU$15.02bn
- AU$9.65bn
- 87
- 84
- 43
- 81
Annual income statement for Sonic Healthcare, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8,754 | 9,340 | 8,169 | 8,967 | 9,645 |
Cost of Revenue | |||||
Gross Profit | 7,137 | 7,736 | 6,889 | 7,516 | 8,084 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 6,833 | 7,183 | 7,151 | 8,085 | 8,714 |
Operating Profit | 1,921 | 2,157 | 1,018 | 882 | 931 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 1,829 | 2,077 | 931 | 731 | 751 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,348 | 1,515 | 708 | 544 | 544 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1,315 | 1,461 | 685 | 511 | 514 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,315 | 1,461 | 685 | 511 | 514 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.74 | 3.03 | 1.45 | 1.04 | 1.07 |
Dividends per Share |